General
Indonesia turns to China for more vaccines after AstraZeneca delays
Indonesia is in talks with China to secure as many as 100 million COVID-19 vaccine doses to plug a gap in deliveries after delays in the arrival of AstraZeneca shots.
Key points:
- China’s Sinovac has already supplied about 56 million doses to Indonesia
- AstraZeneca Indonesia aims to start its first deliveries in June
- More than 9.22 million people in Indonesia have already received at least one shot of a COVID-19 vaccine
Indonesia’s Health Minister, Budi Gunadi Sadikin, told a parliamentary hearing on Thursday the country would receive 20 million doses of the AstraZeneca vaccine via a bilateral deal in 2021, instead of the 50 million initially agreed upon.
The remaining 30 million doses were due to be shipped by the second quarter of 2022, he…
-
Business12 hours agoSilver reaches a 14-year high. Will it outperform the gold price this year?
-
Business17 hours agoWhere I’d invest $5,000 into ASX dividend shares right now
-
Business14 hours ago$20,000 in savings? Here’s how to target $1,000 of passive income each month
-
Noosa News14 hours agoSunraysia wine grape grower’s chemical-free approach a point of difference in tight market